LivingGLP1
Study S002047

Bioenergetic Alterations After Exenatide Administration

Registration

Registration
NCT00623545
Study type
INTERVENTIONAL
Phase
PHASE4
Masking
NONE
Status
COMPLETED
Enrollment
28
Start
2008-01
Primary completion
2010-04
Lead sponsor
University of Wisconsin, Madison
Conditions
Healthy
Interventions
DRUG:Exenatide
Results posted
TRUE

Registered primary outcomes

  • Change in Energy Intake Measured Before Treatment and at the End of Treatment. [3 months]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0026590Alterations in energy balance following exenatide administration.
Bradley DP, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
2012Other trialPMID 22735035DOIcites ClinicalTrials.gov:NCT00623545; registry reference DERIVED:22735035
R0021148Exenatide and weight loss.
Bradley DP, Nutrition (Burbank, Los Angeles County, Calif.)
2010Narrative reviewPMID 20152707DOIregistry reference RESULT:20152707